TGen, Persistent Developing Commercial Version of Biospecimen Management System | GenomeWeb

NEW YORK (GenomeWeb News) – Persistent Systems and the Translational Genomics Research Institute announced they are developing a commercial version of a biospecimen management system.

Called Bio4D, initial versions of the software have been used at TGen in research into the underlying causes of diseases. The partners will now develop a commercial version to manage the collection, processing, storage, distribution, and analysis of biospecimens including blood, DNA, and tissue samples, such as samples from cancer biopsies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: proteomic consequences of genomic changes in ovarian cancer, Human SRMAtlas, and more.

At Nature, John Wilbanks and Eric Topol call for openness in health data.

Law.com predicts that genomic and genetic testing will become common in toxic tort cases.

A Pew Research Center report finds that most Americans are wary of using technologies like gene editing to enhance human abilities.